US stocks Tuesday shook off early losses and closed ... as a “tailwind” for its sleep apnea and CPAP business. Insulet (PODD) ...

The S&P 500 and the Nasdaq both closed Tuesday's session around 0.2% higher ... provider that enjoyed a positive trading day. Insulet (PODD) shares jumped 6.6% after the Food and Drug ...

Insulet (PODD) closed up more than +6% to lead gainers in the S&P 500. Insulet added to Tuesday’s 6% jump after receiving FDA ...

Insulet (PODD) closed up more than +2% to lead gainers in the S&P 500. Insulet is adding to Tuesday’s 6% jump after the company received FDA clearance for its Omnipod 5 to treat people with Type 2 ...

U.S. stocks struggled for direction on Tuesday, as investors eagerly awaited Nvidia's highly anticipated earnings report.

Investors interested in stocks from the Medical - Products sector have probably already heard of Baxter International (BAX) and Insulet (PODD). But which of these two stocks is more attractive to ...

Brown Capital Management Mid Company Fund highlighted stocks like Insulet Corporation (NASDAQ:PODD), in the second quarter 2024 investor letter. Insulet Corporation (NASDAQ:PODD) develops and ...

Insulet Corp.’s PODD recent FDA approval of Omnipod 5 for type 2 diabetes patients is set to expand the product’s market potential. The planned launch of Omnipod 5 with Abbott’s Freestyle ...